Trial intelligence / Profile preview

VN-0103 Ph3 study

jRCT2080222484Phase 3

Sponsor
Daiichi Sankyo Co., Ltd.
Start
May 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of VN-0103 in diphtheria, Tetanus and pertussis (2 arms), sponsored by Daiichi Sankyo Co., Ltd.

02

Drugs

VN-0103
03

Conditions

diphtheriaTetanuspertussis

Beyond the preview

Go deeper on jRCT2080222484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call